ISOTRETINOIN MEDICATION PROGRAM: ALERTING YOU TO THE RISKS OF TERATOGENICITY (I.M.P.A.R.T.)
DEAD

Serial Number

76516376

Owner

Ranbaxy Laboratories Limited

Attorney

JAYADEEP R. DESHMUKH

First Use Date

Feb 13, 2003

Filing Date

May 22, 2003

Add to watchlist:

No watchlists yet
View on USPTO

ISOTRETINOIN MEDICATION PROGRAM: ALERTING YOU TO THE RISKS OF TERATOGENICITY (I.M.P.A.R.T.) Trademark

Serial Number: 76516376 • Registration: 2836216

ISOTRETINOIN MEDICATION PROGRAM: ALERTING YOU TO THE RISKS OF TERATOGENICITY (I.M.P.A.R.T.) is a trademark filed by Ranbaxy Laboratories Limited on May 22, 2003. The trademark is classified under Class 16 (Paper Goods). The application is currently no longer active.

Owner Contact Info

Ranbaxy Laboratories Limited (297 trademarks)

19 Nehru Place
New Delhi , IN

Entity Type: 03

Trademark Details

Filing Date

May 22, 2003

Registration Date

April 27, 2004

First Use Anywhere

February 13, 2003

First Use in Commerce

February 13, 2003

Published for Opposition

February 3, 2004

Cancellation Date

December 3, 2010

Goods & Services

Printed instructional and educational materials used for counseling to healthcare professionals to provide patients with information on the importance of pregnancy prevention while undergoing treatment with a pharmaceutical preparation associated with fetal abnormalities

Filing History

CANCELLED SEC. 8 (6-YR)
Dec 3, 2010 C8..
REGISTERED-PRINCIPAL REGISTER
Apr 27, 2004 R.PR
PUBLISHED FOR OPPOSITION
Feb 3, 2004 PUBO
NOTICE OF PUBLICATION
Jan 14, 2004 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 1, 2003 CNSA
EXAMINERS AMENDMENT E-MAILED
Nov 24, 2003 GNEA
ASSIGNED TO EXAMINER
Nov 24, 2003 DOCK